资产档案
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
最新在前。
Palatin 在 2026 年 ObesityWeek 大会上展示 MC4R 激动剂 PL2001 的临床前数据
同一家公司在本板块内跟踪的其他药物和在研候选。